Impact of a Nationwide Remote Patient Care Hypertension Program on Clinical and Health Care Cost and Utilization Outcomes
Feldman et al.
The finding, in our words
A remote patient monitoring programme enrolling 7256 Medicare patients with hypertension (mean age 73 years, 54.5% rural/underserved) achieved a mean blood pressure reduction of 8/4 mm Hg over 49 weeks and improved BP control while reducing inpatient admissions and spending. This shows scalable clinical and economic benefits of technology-enabled remote care for chronic disease management.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
A 2025 review from China finds decentralised trials still far from standard practice despite the enthusiasm of regulators and industry, and names the operational gaps that keep them so: technology, oversight and data quality.
In a large decentralised hypertension trial of 21,104 adults, nearly half used their own home blood pressure monitors for remote monitoring, but 18.7% of identifiable devices lacked validation against standardised protocols despite costing substantially less than validated models. This reveals a critical gap in device quality for decentralised trials relying on patient-owned equipment.
Anbarasan et al., Journal of human hypertension · source ↗
The study observed favourable trends in the accrual of participants residing far from the site and those from underrepresented groups following the implementation of a decentralised clinical trial program.
This study validated a low-cost 3D-printed smartphone attachment and paper sensor for measuring glucose, uric acid and cholesterol in saliva, demonstrating high correlation with standard ELISA results in a small clinical cohort. The authors suggest this platform offers a scalable solution for decentralised diabetes management by balancing sensitivity with affordability.
Yang et al., Biosensors & bioelectronics (paywalled) · source ↗
This proof-of-concept study demonstrated that patients with inflammatory bowel disease could successfully perform capillary blood microsampling at home with high analytical success rates, and a majority preferred this decentralised approach over hospital venous draws.
Schuurman et al., Inflammatory bowel diseases · source ↗